Free Trial

ENDRA Life Sciences Q3 2023 Earnings Report

ENDRA Life Sciences logo
$3.93 -0.16 (-3.91%)
As of 11:41 AM Eastern

ENDRA Life Sciences EPS Results

Actual EPS
-$700.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ENDRA Life Sciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

ENDRA Life Sciences Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Remove Ads

ENDRA Life Sciences Earnings Headlines

Your Retirement Is Caught in the Crossfire
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.
ENDRA Life Sciences (NDRA) to Release Earnings on Thursday
ENDRA Life Sciences Inc Registered Shs NDRA
See More ENDRA Life Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ENDRA Life Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ENDRA Life Sciences and other key companies, straight to your email.

About ENDRA Life Sciences

ENDRA Life Sciences (NASDAQ:NDRA) develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

View ENDRA Life Sciences Profile

More Earnings Resources from MarketBeat